Regeneron’s clinical trials are at the core of this mission. Regeneron is grateful to all clinical trial participants — ...

An international, Phase III clinical trial led by investigators at Mass General Brigham could improve the treatment of a rare ...

More than 48 million Americans 12 years or older had a substance use disorder in 2022, yet only 24 percent received treatment ...

Amid tightening EU regulations, a growing emphasis on digitalisation and artificial intelligence (AI), and complex questions ...

This week, the health system announced its first clinical affiliation with Aultman, a nonprofit health care organization ...

I have the benefit of extensive experience in clinical trials and caring for many patients. It is rewarding to bring this ...

The ISBI announced that Dr. Kaitlin Pruskowski, a clinical pharmacist with USAISR, has been appointed a member of its ...

The AD risk factors/hits include high exposure to traffic-related air pollution (TRAP) and infections, as well as factors ...

The beauty giant plans to unleash AI across its entire portfolio, including Clinique, La Mer, Bobbie Brown, Aveda and more.

In a small subset of those patients, the combination resulted in a strong response with tumor shrinkage and no disease ...